Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
38,862,958
-
Share change
-
+2,450,542
-
Total reported value
-
$1,843,568,179
-
Put/Call ratio
-
84%
-
Price per share
-
$47.39
-
Number of holders
-
126
-
Value change
-
+$59,854,597
-
Number of buys
-
68
-
Number of sells
-
67
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2021
As of 31 Dec 2021,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,862,958 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, HHLR ADVISORS, LTD., BlackRock Inc., Cederberg Capital Ltd, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Zeal Asset Management Ltd, Octagon Capital Advisors LP, PICTET ASSET MANAGEMENT SA, and VANGUARD GROUP INC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.